Agilent, a medical equipment provider reported higher-than-expected Q4 profit and revenue.
Non-GAAP EPS increased to $0.59 in the August-to-October quarter, from $0.50 a year ago, topping the $0.52 average estimate of analysts polled by Capital IQ. Q4 revenue increased 7% to $1.111 billion year-over-year, also surpassing the analyst consensus of $1.06 billion.
Looking ahead, Agilent expects Q1 non-GAAP EPS in the range of $0.48 to $0.50, below the analyst consensus of $0.53. It anticipates Q1 revenue in the range of $1.04 billion to $1.06 billion, also below the analyst average estimate of $1.08 billion.
For fiscal year 2017, Agilent expects revenue of $4.35 billion to $4.37 billion and non-GAAP EPS of $2.10 to $2.16. Analysts are looking for $4.36 billion in revenue and $2.19 in EPS.